Stock 4549 EIKEN CHEMICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Eiken Chemical Co., Ltd. Stock

Equities

4549

JP3160700005

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-16 am EDT 		5-day change 1st Jan Change
1,996 JPY -0.20% Intraday chart for Eiken Chemical Co., Ltd. -0.55% +16.79%
Mar. 21 Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024. CI
Mar. 19 Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million. CI

Financials

Sales 2024 * 40.32B 261M Sales 2025 * 41.82B 270M Capitalization 71.2B 460M
Net income 2024 * 3.47B 22.45M Net income 2025 * 3.54B 22.87M EV / Sales 2024 * 1.43 x
Net cash position 2024 * 13.74B 88.83M Net cash position 2025 * 14.48B 93.67M EV / Sales 2025 * 1.36 x
P/E ratio 2024 *
21.3 x
P/E ratio 2025 *
20.6 x
Employees 754
Yield 2024 *
2.5%
Yield 2025 *
2.5%
Free-Float 75.39%
More Fundamentals * Assessed data

Chart Eiken Chemical Co., Ltd.

Dynamic Chart

Latest news about Eiken Chemical Co., Ltd.

Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024. CI
Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million. CI
Eiken Chemical Co., Ltd. announces an Equity Buyback for 2,700,000 shares, representing 7.28% for ¥5,400 million. CI
Eiken Chemical Co., Ltd. authorizes a Buyback Plan. CI
Lucira Health, Inc. Provides Notice of Termination of the Patent License Agreement by and Between the Company and Eiken Chemical Co., Ltd CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2020 CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019 CI
Medicinal Genomics Corp. Partners with Eiken Chemical Co., Ltd. for Cannabis Testing to Drive Higher Yield CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2019 CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018 CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Announces Dividend for the Six Months Ended September 30, 2017, Payable on December 1, 2017; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018 CI
Eiken Chemical Co., Ltd. Revised Consolidated and Non Consolidated Earnings Guidance for the First Six Months of Fiscal Year Ending September 30, 2017 CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the First Half Year of Fiscal 2018 and Full Year Ending March 2018 CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal First Half of 2018 and Full Year of 2018; Declares Consolidated Dividend for the Year Ended March 31, 2017, Payable on June 5, 2017; Provides Dividend Guidance for the Fiscal First Half of 2018 and Full Year of 2018 CI
Eiken Chemical Co., Ltd. Revises Consolidated and Non Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2017 CI
More news

Press releases Eiken Chemical Co., Ltd.

Eiken Chemical : Consolidated Financial Results for the Six Months Ended September 30, 2023 PU
Eiken Chemical : Business Results for the First Three Months of fiscal year ending March 31, 2024 PU
Eiken Chemical : Bridge Report for the Fiscal Year Ended March 31, 2023 PU
Eiken Chemical : Business Results for the Fiscal Year Ended March 31, 2023 PU
Eiken Chemical : Business Results for the First Nine Months of fiscal year ending March 31, 2023 PU
More press releases

Quotes and Performance

1 day-0.20%
1 week-0.55%
Current month-0.20%
1 month+3.31%
3 months+9.85%
6 months+39.09%
Current year+16.79%
More quotes

Highs and lows

1 week
1 965.00
Extreme 1965
2 049.00
1 month
1 912.00
Extreme 1912
2 049.00
Current year
1 678.00
Extreme 1678
2 055.00
1 year
1 334.00
Extreme 1334
2 055.00
3 years
1 334.00
Extreme 1334
2 340.00
5 years
1 334.00
Extreme 1334
2 600.00
10 years
778.00
Extreme 778
2 862.00
More quotes

Managers and Directors - Eiken Chemical Co., Ltd.

Managers TitleAgeSince
Tsugunori Notomi PSD
 President 65 81-03-31
Hidetoshi Kanda CTO
 Chief Tech/Sci/R&D Officer 63 85-02-28
Hajime Watari ADM
 Chief Administrative Officer 63 85-02-28
Members of the board TitleAgeSince
Akira Fujiyoshi BRD
 Director/Board Member 70 20-06-22
Morifumi Wada BRD
 Director/Board Member 69 78-02-28
Tsugunori Notomi PSD
 President 65 81-03-31
More insiders

ETFs positioned on Eiken Chemical Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY ETF Nomura NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY
0.15% 15 M€ +5.04%
DAIWA ETF MSCI JAPAN EMPOWERING WOMEN INDEX ETF - JPY ETF Daiwa ETF MSCI Japan Empowering Women Index ETF - JPY
0.02% 4 M€ +15.53%
NZAM ETF TOPIX EX-FINANCIALS - JPY ETF NZAM ETF TOPIX Ex-Financials - JPY
0.01% 18 M€ +16.15% -
MAXIS TOPIX ETF - JPY ETF MAXIS TOPIX ETF - JPY
0.01% 20,721 M€ +14.03% -
NOMURA TOPIX EXCHANGE TRADED FUND ETF - JPY ETF Nomura TOPIX Exchange Traded Fund ETF - JPY
0.01% 144,586 M€ +15.01%
More ETFs positioned on Eiken Chemical Co., Ltd.

Quotes

Date Price Change Volume
24-04-16 1,996 -0.20% 94 500
24-04-15 2,000 +0.05% 72,400
24-04-12 1,999 -1.14% 129,400
24-04-11 2,022 +0.05% 94,400
24-04-10 2,021 +0.70% 98,900

Delayed Quote Japan Exchange, April 16, 2024 at 02:00 am EDT

More quotes

Company Profile

EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-05-08 - Q4 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Eiken Chemical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
2,000 JPY
Average target price
1,750 JPY
Spread / Average Target
-12.50%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
EIKEN CHEMICAL CO., LTD. Stock Eiken Chemical Co., Ltd.
+16.79% 462M
ABBOTT LABORATORIES Stock Abbott Laboratories
-1.07% 189B
MEDTRONIC PLC Stock Medtronic plc
-2.61% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.74% 67.81B
DEXCOM, INC. Stock DexCom, Inc.
+8.44% 51.87B
CENCORA, INC. Stock Cencora, Inc.
+14.04% 46.67B
HOYA CORPORATION Stock Hoya Corporation
-0.77% 38.68B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+7.58% 27.73B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.52% 26.6B
SARTORIUS STEDIM BIOTECH Stock Sartorius Stedim Biotech
+4.89% 26.34B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 4549 Stock